These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2812191)

  • 1. [Bone and joint complications in patients treated with continuous ambulatory peritoneal dialysis (CAPD) for more than 3 years].
    Dratwa M; Wens R; Collart F; Tielemans C
    Nephrologie; 1989; 10 Suppl():56-61. PubMed ID: 2812191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Renal osteodystrophy in dialysis patients as estimated by three-point bone densitometry].
    Kucharska E; Stompór T; Sułowicz W; Drozdz M; Kaczmarczyk I; Szymczakiewicz-Multanowska A; Chruściel B; Kraśnicka M
    Przegl Lek; 2000; 57(6):334-9. PubMed ID: 11107868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal osteodystrophy in CAPD patients.
    Zucchelli P; Catizone L; Casanova S; Fusaroli M; Fabbri L; Ferrari G
    Miner Electrolyte Metab; 1984; 10(5):326-32. PubMed ID: 6493161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral and aluminum concentrations in patients undergoing CAPD.
    Giangrande A; Costanini S; Ballanti P; Castiglioni A; Caligara F; Pisoni B; Giordano R; Vernillo I; Berni S; Bonucci E
    Adv Perit Dial; 1992; 8():351-5. PubMed ID: 1361821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Renal osteodystrophy and growth in children undergoing CAPD].
    Ito T; Horiike S; Iitaka K
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):779-90. PubMed ID: 1770638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Losses of 25-hydroxyvitamin D in peritoneal fluid: possible mechanism for bone disease in uremic patients treated with chronic ambulatory peritoneal dialysis.
    Aloni Y; Shany S; Chaimovitz C
    Miner Electrolyte Metab; 1983; 9(2):82-6. PubMed ID: 6601753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of calcifediol treatment on the progression of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G; Lorenz M; Cresseri D
    Nephron; 1990; 56(4):353-6. PubMed ID: 2079992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal osteodystrophy and aluminum bone disease in CAPD patients.
    Gokal R
    Clin Nephrol; 1988; 30 Suppl 1():S64-7. PubMed ID: 3052962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
    Lorenzo Sellares V; Torregrosa V
    Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of renal osteodystrophy during continuous ambulatory peritoneal dialysis.
    Buccianti G; Bianchi ML; Valenti G
    Clin Nephrol; 1984 Dec; 22(6):279-83. PubMed ID: 6525771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in calcium kinetic pattern between CAPD and HD patients.
    Kurz P; Tsobanelis T; Roth P; Werner E; Ewald U; Grützmacher P; Schoeppe W; Vlachojannis J
    Clin Nephrol; 1995 Oct; 44(4):255-61. PubMed ID: 8575126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of DEXA bone densitometry in evaluating renal osteodystrophy in continuous ambulatory peritoneal dialysis patients.
    Johnson DW; McIntyre HD; Brown A; Freeman J; Rigby RJ
    Perit Dial Int; 1996; 16(1):34-40. PubMed ID: 8616170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal osteodystrophy in children undergoing continuous ambulatory peritoneal dialysis.
    Hewitt IK; Stefanidis C; Reilly BJ; Kooh SW; Balfe JW
    J Pediatr; 1983 Nov; 103(5):729-34. PubMed ID: 6631599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of ionized calcium and 1,25-dihydroxycholecalciferol loss from peritoneal fluid during peritonitis in patients treated with continuous ambulatory peritoneal dialysis.
    Lin CY; Huang TP
    Nephron; 1991; 59(1):90-5. PubMed ID: 1944754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD.
    Salusky IB; Ramirez JA; Oppenheim W; Gales B; Segre GV; Goodman WG
    Kidney Int; 1994 Jan; 45(1):253-8. PubMed ID: 8127016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evolution of renal osteodystrophy in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Calderaro V; Oreopoulos DG; Meema HE; Ogilvie R; Husdan H; Khanna R; Quinton C; Murray T; Carmichael D
    Proc Eur Dial Transplant Assoc; 1980; 17():533-42. PubMed ID: 6787584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low turnover bone disease is the more common form of bone disease in CAPD patients.
    Rodriguez-Perez JC; Plaza C; Torres A; Vega N; Anabitarte A; Fernandez A; Lorenzo V; Hortal L; Palop L
    Adv Perit Dial; 1992; 8():376-80. PubMed ID: 1361827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamics of menatetrenone and effects on bone metabolism in continuous ambulatory peritoneal dialysis patients.
    Sugimoto T; Yamakado M; Matsushita K; Iwamoto T; Tagawa H
    J Int Med Res; 2002; 30(6):566-75. PubMed ID: 12526283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D therapy in CAPD: what is its role?
    Hutchison AJ; Gokal R
    Adv Perit Dial; 1993; 9():253-6. PubMed ID: 8105937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.